Health Care Equipment

LOGICMARK INC

LOGICMARK INC released FY2025 Q3 earnings on November 12 After-Market (EST), actual revenue USD 2.915 M (forecast USD 2.722 M), actual EPS USD -2.213

LOGICMARK INC released FY2025 9 Months Earnings on November 12 After-Market EST, actual revenue USD 8.36 M, actual EPS USD -98.6161

LOGICMARK INC to release FY2025 Q3 earnings on November 12 After-Market EST, forecast revenue USD 2.722 M

LOGICMARK INC released FY2025 Q2 earnings on August 13 (EST), actual revenue USD 2.853 M (forecast USD 2.348 M), actual EPS USD -2.9026

LOGICMARK INC released FY2024 Semi-Annual earnings on August 13, 2025 (EST), with actual revenue of USD 4.947 M and EPS of USD 0

LOGICMARK INC released FY2024 Q2 earnings on August 13 (EST), actual revenue USD 2.336 M (forecast USD 2.374 M), actual EPS USD 0

LOGICMARK INC released FY2025 Semi-Annual earnings on August 13 (EST), actual revenue USD 5.445 M, actual EPS USD -11.6041

LOGICMARK INC released FY2024 Q1 earnings on May 15 (EST), actual revenue USD 2.611 M (forecast USD 2.838 M), actual EPS USD 0

LOGICMARK INC released FY2025 Q1 earnings on May 15 (EST), actual revenue USD 2.592 M (forecast USD 2.627 M), actual EPS USD -93.5005

LOGICMARK INC released FY2023 earnings on March 31 (EST), actual revenue USD 9.93 M (forecast USD 9.784 M), actual EPS USD 0

LOGICMARK INC released FY2024 Annual Earnings on March 31 (EST), Actual Revenue: USD 9.902 M (Forecast: USD 9.885 M), Actual EPS: USD 0

LOGICMARK INC released FY2023 Q4 earnings on March 31 (EST), actual revenue USD 2.426 M (forecast USD 2.28 M), actual EPS USD 0

LOGICMARK INC released FY2024 Q4 earnings on March 31 (EST), actual revenue USD 2.249 M (forecast USD 2.232 M), actual EPS USD 0

LOGICMARK INC released FY2024 9 Months Earnings on November 14, 2024 (EST) with actual revenue of USD 7.653 M and EPS of USD 0

LOGICMARK INC released FY2023 Q3 earnings on November 14 (EST), actual revenue USD 2.367 M (forecast USD 2.35 M), actual EPS USD 0

LOGICMARK INC released FY2024 Q3 earnings on November 14 (EST), actual revenue USD 2.705 M (forecast USD 2.438 M), actual EPS USD 0

A SPAC III Acquisition

ECD Automotive Design

Davis Commodities

A SPAC III ACQUISITION CORP. COM NPV CL A (SUBS/RTS)02/01/2026

CID Holdco

Sidus Space

Can-Fite BioPharma

PicoCELA

Paranovus ENT Tech

Highway

Delcath

Electromed

Abbott Laboratories

Intuitive Surgical

Boston Scientific

Stryker

IDEXX Labs

Edwards Lifesciences

Resmed

DexCom

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap